| Revenue Disaggregation |
| Note 10. |
Revenue Disaggregation |
The Company generates product revenues from products
which are sold into the human and animal healthcare markets.
The following table presents the Company’s disaggregated revenues
by source:
| Schedule of disaggregated revenues |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended September 30, |
|
|
Six Months Ended September 30, |
|
| |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
| Human Care |
|
$ |
6,782,000 |
|
|
$ |
5,116,000 |
|
|
$ |
12,749,000 |
|
|
$ |
8,671,000 |
|
| Animal Care |
|
|
392,000 |
|
|
|
488,000 |
|
|
|
831,000 |
|
|
|
948,000 |
|
| |
|
$ |
7,174,000 |
|
|
$ |
5,604,000 |
|
|
$ |
13,580,000 |
|
|
$ |
9,619,000 |
|
The following table shows the Company’s revenues by geographic region:
| Schedule of revenues by geographic region |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended September 30, |
|
|
Six Months Ended September 30, |
|
| |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
| United States |
|
$ |
2,796,000 |
|
|
$ |
1,449,000 |
|
|
$ |
5,222,000 |
|
|
$ |
2,454,000 |
|
| Europe |
|
|
2,148,000 |
|
|
|
2,151,000 |
|
|
|
4,112,000 |
|
|
|
3,619,000 |
|
| Asia |
|
|
801,000 |
|
|
|
1,057,000 |
|
|
|
1,711,000 |
|
|
|
1,719,000 |
|
| Latin America |
|
|
835,000 |
|
|
|
532,000 |
|
|
|
1,461,000 |
|
|
|
1,096,000 |
|
| Rest of the World |
|
|
594,000 |
|
|
|
415,000 |
|
|
|
1,074,000 |
|
|
|
731,000 |
|
| Total |
|
$ |
7,174,000 |
|
|
$ |
5,604,000 |
|
|
$ |
13,580,000 |
|
|
$ |
9,619,000 |
|
|